Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vitreo Retinal Associates of Florida is a specialized medical practice dedicated to the diagnosis and treatment of vitreoretinal diseases, including macular degeneration, diabetic retinopathy, and retinal detachment. Headquartered in Gainesville, Florida, the practice operates multiple clinical locations and serves as a prominent center for ophthalmic clinical research. The group participates in numerous Phase 1 through Phase 3 clinical trials, evaluating next-generation therapies such as gene treatments and novel biologics for blinding eye diseases. In 2020, the practice joined Retina Consultants of America (RCA), a national consortium of leading retina specialists backed by private equity. This partnership enhances their ability to provide cutting-edge diagnostic imaging and advanced surgical interventions to patients across North Central Florida.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vitreo Retinal Associates Florida.